Get started
Author

Nihal Shah

6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
2019 · Helena M Earl, Louise Hiller, et al. · The Lancet · 300
PDF
Low dose hyper-radiosensitivity in metastatic tumors
2004 · Jackie Harney, Susan C. Short, et al. · International Journal of Radiation Oncology*Biology*Physics · 67
The evaluation of low dose hyper-radiosensitivity in normal human skin
2004 · Jackie Harney, Nihal Shah, et al. · Radiotherapy and Oncology · 40
The impact of FDG positron emission tomography imaging on the management of lymphomas.
2000 · N Shah, P Hoskin, et al. · British Journal of Radiology · 39
High FDG Uptake in a Schwanomma: A PET Study
2000 · Nihal Shah, Amen Sibtain, et al. · Journal of Computer Assisted Tomography · 27
Neurally Mediated Syncope: Pathophysiology and Implications for Treatment
1999 · Rose Marie Robertson, Eduardo Medina, et al. · The American Journal of the Medical Sciences · 27
A Pilot Study of Postoperative CHART and CHARTWEL in Head and Neck Cancer
2000 · N. Shah, M.I. Saunders, et al. · Clinical Oncology · 23
Toxicity and outcome of a phase II trial of taxane‐based neoadjuvant chemotherapy and 3‐dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer
2006 · Ana M. Rojas, Basil E. Lyn, et al. · Cancer · 14
PDF
A pilot study to assess the feasibility of prior scalp cooling with palliative whole brain radiotherapy.
2000 · N Shah, N Groom, et al. · British Journal of Radiology · 13
The modification of human tumour blood flow using pentoxifylline, nicotinamide and carbogen
2002 · Amen Sibtain, Sally Hill, et al. · Radiotherapy and Oncology · 8
New approach to the reconstruction of defects deep in the orbital roof
2018 · N. Shah, S. Kassam, et al. · British Journal of Oral and Maxillofacial Surgery · 2
Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience
2024 · S. Armstrong, A. Makris, et al. · Clinical Oncology · 1
4418 Analysis on the selection of optimal planning methodology, dose reporting for the PTV and associated uncertainties in lung SABR
2026 · Jose Solomon Raj Lourdhurajan, Prasana Sarathy Nariyangadu, et al. · Radiotherapy and Oncology
Incidence of Pneumonitis with Concurrent Trastuzumab Emtansine (T-DM1) and Radiotherapy in HER2-Positive Breast Cancer: A retrospective review
2026 · Estabrak Jiad, Charlotte Westbury, et al. · Clinical Oncology
Real-world timing and incidence of haematologic adverse events with adjuvant abemaciclib: Implications for clinical practice
2026 · Amit Samani, Roshni Dasgupta, et al. · Clinical Oncology
3504 Single centre experience of using stereotactic ablative body radiotherapy (SABR) to treat primary renal cell carcinoma on the Cyberknife® Machine
2025 · Riya Patel, Julie Duong, et al. · Radiotherapy and Oncology
560: Outcomes of stereotactic body radiotherapy on oligometastatic and oligoprogressive breast cancer
2024 · Shreya Armstrong, Andreas Makris, et al. · Radiotherapy and Oncology
2987: Treatment outcomes of SABR on oligometastases from rare primary cancers
2024 · Rupinder Talwar, Julie Duong, et al. · Radiotherapy and Oncology
3080: Clinical outcomes following stereotactic ablative body radiotherapy to central lung tumours
2024 · Julie Duong, Riya Patel, et al. · Radiotherapy and Oncology
Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
2021 · Jonathan Groves, Ryan Yeo, et al. · European Respiratory Journal
Papillary carcinoma arising from thyroglossal duct cysts
2009 · Kaveh Shakib, Syedda Abbas, et al. · British Journal of Oral and Maxillofacial Surgery
1020 Low dose hyper-radiosensitivity — Is it a clinical reality and can it influence the radiation schedules used in the treatment of gliomas?
1999 · M.I. Saunders, N. Shah, et al. · International Journal of Radiation Oncology*Biology*Physics
Works count: 22
Citation count: 561
H-index: 9
I10-index: 9
Year
Topic
Type